Literature DB >> 11751850

GIPC participates in G protein signaling downstream of insulin-like growth factor 1 receptor.

Ronald A Booth1, Cathy Cummings, Mario Tiberi, X Johné Liu.   

Abstract

Several recent studies have demonstrated that insulin-like growth factor (IGF)-1-induced mitogen-activated protein kinase (MAP kinase) activation is abolished by pertussis toxin, suggesting that trimeric G proteins of the G(i) class are novel cellular targets of the IGF-1 signaling pathway. We report here that the intracellular domain of the Xenopus IGF-1 receptor is capable of binding to the Xenopus homolog of mammalian GIPC, a PDZ domain-containing protein previously identified as a binding partner of G(i)-specific GAP (RGS-GAIP). Binding of xGIPC to xIGF-1 receptor is independent of the kinase activity of the receptor and appears to require the PDZ domain of xGIPC. Injection of two C-terminal truncation mutants that retained the PDZ domain blocked IGF-1-induced Xenopus MAP kinase activation and oocyte maturation. While full-length xGIPC injection did not significantly alter insulin response, it greatly enhanced human RGS-GAIP in stimulating the insulin response in frog oocytes. This represents the first demonstration that GIPC x RGS-GAIP complex acts positively in IGF-1 receptor signal transduction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11751850     DOI: 10.1074/jbc.M108033200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  A method for generation of arbitrary peptide libraries using genomic DNA.

Authors:  Haiming Huang; Youhe Gao
Journal:  Mol Biotechnol       Date:  2005-06       Impact factor: 2.695

2.  GIPC is recruited by APPL to peripheral TrkA endosomes and regulates TrkA trafficking and signaling.

Authors:  Tal Varsano; Meng-Qiu Dong; Ingrid Niesman; Hyacynth Gacula; Xiaojing Lou; Tianlin Ma; Joseph R Testa; John R Yates; Marilyn G Farquhar
Journal:  Mol Cell Biol       Date:  2006-10-02       Impact factor: 4.272

Review 3.  Directing traffic in neural cells: determinants of receptor tyrosine kinase localization and cellular responses.

Authors:  Robert J Romanelli; Teresa L Wood
Journal:  J Neurochem       Date:  2008-06-01       Impact factor: 5.372

Review 4.  How regulators of G protein signaling achieve selective regulation.

Authors:  Guo-Xi Xie; Pamela Pierce Palmer
Journal:  J Mol Biol       Date:  2006-11-15       Impact factor: 5.469

5.  Polar body emission requires a RhoA contractile ring and Cdc42-mediated membrane protrusion.

Authors:  Xuan Zhang; Chunqi Ma; Ann L Miller; Hadia Arabi Katbi; William M Bement; X Johné Liu
Journal:  Dev Cell       Date:  2008-09       Impact factor: 12.270

Review 6.  An inside view: VEGF receptor trafficking and signaling.

Authors:  Michael Simons
Journal:  Physiology (Bethesda)       Date:  2012-08

7.  Translation of incenp during oocyte maturation is required for embryonic development in Xenopus laevis.

Authors:  Geoffrey G Leblond; Heather Sarazin; Ruizhen Li; Makoto Suzuki; Naoto Ueno; X Johné Liu
Journal:  Biol Reprod       Date:  2012-05-31       Impact factor: 4.285

8.  Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.

Authors:  David Ghez; Yves Lepelletier; Sophie Lambert; Jean-Marie Fourneau; Vincent Blot; Sébastien Janvier; Bertrand Arnulf; Peter M van Endert; Nikolaus Heveker; Claudine Pique; Olivier Hermine
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

9.  GIPC proteins negatively modulate Plexind1 signaling during vascular development.

Authors:  Jorge Carretero-Ortega; Zinal Chhangawala; Shane Hunt; Carlos Narvaez; Javier Menéndez-González; Carl M Gay; Tomasz Zygmunt; Xiaochun Li; Jesús Torres-Vázquez
Journal:  Elife       Date:  2019-05-03       Impact factor: 8.140

10.  Integrin alpha5beta1 function is regulated by XGIPC/kermit2 mediated endocytosis during Xenopus laevis gastrulation.

Authors:  Erin Spicer; Catherine Suckert; Hyder Al-Attar; Mungo Marsden
Journal:  PLoS One       Date:  2010-05-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.